Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block vs Dexketoprofen for Renal Colic
NCT04209439Phase 4Completed
- Sponsor
- Atatürk University
- Start
- Jan 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in Renal colic (2 arms), sponsored by Atatürk University. Primary endpoint: Number of analgesic consumption at 1 hour. Started Jan 2019; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
Renal colic
Beyond the preview
Go deeper on NCT04209439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04209439.